Goodwin partner Elaine Blais has been recognized by Massachusetts Lawyers Weekly as a Go To Lawyer: Intellectual Property for 2023. Since 2020, Go To Lawyers has showcased the leaders in the Massachusetts legal community across practice areas.
Blais focuses her practice on Intellectual Property Litigation, particularly Patent Litigation. She is known for her first-chair trial skills, strategic instincts, and experience in all areas of patent litigation, with particular expertise in fields including biologics, pharmaceuticals, secure financial transactions, light-emitting diodes, and consumer products. She routinely represents clients in arbitration proceedings, and has first-chaired numerous lawsuits and taken cases to trial in federal courts nationwide.
Massachusetts Lawyers Weekly recognized Blais as both a firm- and industry-wide leader. Within Goodwin, she serves on the firm’s Executive Committee, in addition to its Intellectual Property Steering and Attorney Development Committees. She is the co-founder and editor of the firm’s award-winning biosimilar’s blog, Big Molecule Watch, and she co-chairs Goodwin’s Dobbs Task Force, which helps companies navigate the rapidly evolving landscape surrounding the Dobbs v. Jackson Women’s Health Organization decision.
Blais is routinely recognized for excellence by Chambers USA, The Legal 500 US, IAM Patent 1000, and Managing IP. Recently, she was recognized as a Litigation Star – Intellectual Property by Benchmark Litigation, and as a Best Lawyer for her work in Litigation – Patent by The Best Lawyers in America. In 2020 and 2022, Blais was named General Patent Litigator of the Year: New England by LMG Life Sciences, and in 2021, she was recognized by World Intellectual Property Review as one of the most Influential Women in IP.